ReviewWorld J Clin Cases2021
Anti-tumor effect of statin on pancreatic adenocarcinoma: From concept to precision medicine.
- Journal
- World J Clin Cases
- Published
- 1 June 2021
- Citations
- 8
- Type
- Review
- License
- cc by-nc
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
abstract cc by-nc
A statin is a cholesterol-lowering agent, which inhibits HMG-CoA (3-hydroxy-3-methylglutaryl-coenzyme A) reductase and subsequently reduces the cholesterol precursor, and was first used commercially in 1987. The concept of cholesterol restriction leading to cancer cell dysfunction was proposed in 1992. … Excerpt only: this text is the publisher’s. Read it in full at the source.